Two Sigma Investments’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-21,083
| Closed | -$15.6K | – | 3386 |
|
|
2023
Q4 | $15.6K | Buy |
+21,083
| New | +$15.6K | ﹤0.01% | 2972 |
|
|
2022
Q2 | – | Sell |
-511
| Closed | -$19K | – | 2997 |
|
|
2022
Q1 | $19K | Buy |
+511
| New | +$19K | ﹤0.01% | 2488 |
|
|
2021
Q4 | – | Sell |
-4,290
| Closed | -$310K | – | 3251 |
|
|
2021
Q3 | $310K | Sell |
4,290
-4,957
| -54% | -$358K | ﹤0.01% | 2180 |
|
|
2021
Q2 | $886K | Buy |
9,247
+4,631
| +100% | +$444K | ﹤0.01% | 1740 |
|
|
2021
Q1 | $682K | Buy |
+4,616
| New | +$682K | ﹤0.01% | 1743 |
|
|
2020
Q3 | – | Sell |
-571
| Closed | -$100K | – | 2468 |
|
|
2020
Q2 | $100K | Buy |
+571
| New | +$100K | ﹤0.01% | 1855 |
|